The global probiotics industry was valued at USD 48.88 billion in 2019 and is expected to expand to USD 94.48 billion by 2027, recording a CAGR of 7.9% during the forecast period. In 2019, North America held 16.98% of the total market share. Within this region, the U.S. probiotics market is projected to reach USD 17.99 billion by 2032, driven by the growing preference for probiotic-enriched and immunity-boosting food products due to their health advantages.
The increasing focus on preventive healthcare and rising demand for natural, safe, and health-enhancing products are key factors driving the market forward. Professional bodies and associations are also actively promoting probiotic consumption. For example, the Nutrition Society of Malaysia (NSM) introduced the Probiotics Education Program (PEP) to raise awareness about the health benefits of these products.
Information Source: https://www.fortunebusinessinsights.com/industry-reports/probiotics-market-100083
Growing Popularity of Immunity-Boosting Products During COVID-19
Although the market faced temporary challenges from logistical and economic disruptions caused by the pandemic, consumer demand for health and immune-supportive products has surged. Customers are now more conscious of dietary supplements and functional foods, recognizing their role in improving overall wellness. Probiotics, in particular, are gaining traction for their benefits in supporting digestive health and strengthening immunity, which is expected to fuel future growth.
Several companies have reported higher sales during the pandemic. For instance, in April 2020, Probi—a leading global probiotics brand—witnessed a notable increase in demand as consumers sought immunity-enhancing solutions. This heightened demand is expected to persist as awareness of health and well-being continues to grow.
Report Scope
This report provides detailed insights into the market, highlighting key drivers, challenges, opportunities, and restraints influencing growth during the forecast period. It includes regional market breakdowns, global industry trends, and competitive strategies. The study also reviews significant industry activities such as product launches, mergers, partnerships, and acquisitions between 2020 and 2027.
Key Drivers of Growth
With global obesity rates nearly tripling since 1975, as reported by the World Health Organization (WHO), and chronic health issues like obesity and diabetes on the rise, consumers are increasingly adopting healthier diets, which is fueling demand for probiotic products due to their gut health and immunity-boosting benefits; moreover, technological advancements are enabling companies to better educate consumers, further accelerating their adoption.
Market Segmentation Highlights
In 2019, supermarkets and hypermarkets accounted for 61.33% of global probiotic sales, driven by their wide product availability, attractive promotional offers, and convenient consumer access.
Regional Analysis
Asia-Pacific continues to lead the probiotics market, driven by the traditional consumption of fermented foods and beverages that naturally support digestive health, while North America, valued at USD 8.30 billion in 2019, is projected to experience significant growth between 2020 and 2027 due to the rising prevalence of chronic diseases and increased investments in product innovation.
Competitive Landscape
Innovation remains central to the strategies of leading probiotics companies. Major players are focusing on R&D, launching innovative products, and expanding through partnerships, collaborations, and acquisitions to enhance their global reach and strengthen distribution networks.
Key Market Participants
- Danone S.A. (France)
- Lallemand Inc. (Canada)
- Yakult Honsha Co., Ltd. (Japan)
- Nestlé S.A. (Switzerland)
- DuPont (Danisco A/S) (USA)
- Chr. Hansen (Denmark)
- Kerry Inc. (Ireland)
- Post Holdings, Inc. (USA)
- PepsiCo, Inc. (USA)
- Evolve Biosystems, Inc. (USA)
Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/probiotics-market-100083
Recent Development
- June 2020: Pendulum Therapeutics launched Pendulum Glucose Control, a novel medical probiotic clinically proven to reduce postprandial blood sugar levels and A1C, marking a significant innovation in probiotics for metabolic health management.
